https://www.selleckchem.com/
(larger sample sizes, more randomised controlled trials) to improve the quality of evidence and include cost-effectiveness in the analysis. Spinal cord complications associated with coronavirus infectious disease of 2019 (COVID-19) are being widely reported. The purpose of this systematic review was to summarize so far available pieces of evidence documenting de novo novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) mediated spinal cord demyelinating diseases. Indeed, the spinal demyelinating disorders that have been reported in those patient
Like
Comment
Share
